Hypertrophic Cardiomyopathy: A deadly disease that often goes undetected

The tragic news of Chicago Bears defensive end Gaines Adams, 26, and Southern Indiana center Jeron Lewis, 21, whose sudden deaths are both suspected to be from Hypertrophic Cardiomyopathy (HCM), are vital reminders that this deadly disease often goes undetected.

Hypertrophic Cardiomyopathy (HCM), a genetic disease which results in a thickening of the heart muscle, is the leading cause of sudden death in children and young adults. It accounts for 40 percent of all deaths on athletic playing fields across the country.

Marcia Kelley-Clark, chief deputy coroner for Greenwood County, S.C., said Gaines Adams' relatives were not aware of any kind of medical condition.

University of Southern Indiana spokesman Dan McDonnell said he wasn't aware of any preexisting medical conditions that could have contributed to Jeron's death.

Estimated to affect one in 500 Americans, HCM can be detected and treated allowing patients to live long lives.

College and professional athletes should all have comprehensive cardiac exams to ensure they have healthy hearts free from HCM.

For the younger population of athletes - from elementary school to high school - simply improving pre-participation screening forms and conducting ECG on properly selected children will reduce sudden cardiac death.

Adams and Lewis were in a subset for those at higher risk for sudden cardiac arrest from HCM. African American males, this population represents 50% of all those who die from HCM in the athletic spectrum.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Experts recommend cascade screening over universal lipid screening for familial hypercholesterolemia